Showing results (161-170 of 195) with videos related to
Sort By:
Pageof 20
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 24, 2020
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutationJane C Davies, Isabelle Sermet-Gaudelus, Lutz Naehrlich, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2014
18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndromeNicolas de Prost, Yan Feng, Tyler Wellman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
PET Imaging Reveals Early Pulmonary Perfusion Abnormalities in HIV Infection Similar to SmokingPuja Kohli, Vanessa J Kelly, Kathryn A Hibbert, et al.Age and Ageing|February 10, 2024
Primary and secondary care service use and costs associated with frailty in an ageing population: longitudinal analysis of an English primary care cohort of adults aged 50 and over, 2006-2017Carole Fogg, Tracey England, Shihua Zhu, et al.Hepatology (Baltimore, Md.)|November 27, 2007
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersIndra Neil Guha, Julie Parkes, Paul Roderick, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 30, 2019
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosisSeth Walker, Patrick Flume, John McNamara, et al.Journal of Crohn'S & Colitis|January 24, 2016
Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative ColitisDeborah S Hartman, Daniel E Tracey, Brenda R Lemos, et al.Acta Neuropathologica Communications|September 9, 2018
Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's diseaseSonja Rakic, Yat M A Hung, Matthew Smith, et al.Annals of Medicine|June 23, 2026
The impact of multiple long-term conditions on mortality, progression to kidney failure and health-related quality of life among people with chronic kidney disease: a multicentre cohort study (NURTuRE-CKD)Irene Boateng, Thomas Phillips, Scott Harris, et al.Pageof 20